A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression

Autor: Jair C. Soares, Paolo Zanotti-Fregonara, Paul E. Schulz, Christina L. Burrows, Kathryn Durkin, Giovanna Zunta-Soares, João Quevedo, Albert J. Fenoy, Sudhakar Selvaraj
Rok vydání: 2018
Předmět:
Adult
Male
Longitudinal study
Deep brain stimulation
Deep Brain Stimulation
medicine.medical_treatment
Stimulation
Neuropsychological Tests
Article
lcsh:RC321-571
Depressive Disorder
Treatment-Resistant

Young Adult
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Humans
Medicine
Longitudinal Studies
Medial forebrain bundle
Lead (electronics)
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
Biological Psychiatry
Depression (differential diagnoses)
Psychiatric Status Rating Scales
Motivation
business.industry
Medial Forebrain Bundle
Middle Aged
medicine.disease
Texas
030227 psychiatry
Psychiatry and Mental health
Treatment Outcome
Positron-Emission Tomography
Anesthesia
Antidepressant
Female
business
Treatment-resistant depression
030217 neurology & neurosurgery
Zdroj: Translational Psychiatry, Vol 8, Iss 1, Pp 1-11 (2018)
Translational Psychiatry
ISSN: 2158-3188
DOI: 10.1038/s41398-018-0160-4
Popis: Deep brain stimulation (DBS) to the superolateral branch of the medial forebrain bundle (MFB) has been reported to lead to rapid antidepressant effects. In this longitudinal study, we expand upon the initial results we reported at 26 weeks (Fenoy et al., 2016), showing sustained antidepressant effects of MFB DBS on six patients with treatment-resistant depression (TRD) over 1 year. The Montgomery-Åsberg Depression Rating Scale (MADRS) was used as the primary assessment tool. Deterministic fiber tracking was used to individually map the target area; analysis was performed to compare modulated fiber tracts between patients. Intraoperatively, upon stimulation at target, responders reported immediate increases in energy and motivation. An insertional effect was seen during the 4-week sham stimulation phase from baseline (28% mean MADRS reduction, p = 0.02). However, after 1 week of initiating stimulation, three of six patients had a > 50% decrease in MADRS scores relative to baseline (43% mean MADRS reduction, p = 0.005). One patient withdrew from study participation. At 52 weeks, four of remaining five patients have > 70% decrease in MADRS scores relative to baseline (73% mean MADRS reduction, p = 0.007). Evaluation of modulated fiber tracts reveals significant common orbitofrontal connectivity to the target region in all responders. Neuropsychological testing and 18F-fluoro-deoxyglucose-positron emission tomography cerebral metabolism evaluations performed at baseline and at 52 weeks showed minimal changes and verified safety. This longitudinal evaluation of MFB DBS demonstrated rapid antidepressant effects, as initially reported by Schlaepfer et al. (2013), and supports the use of DBS for TRD.
Databáze: OpenAIRE